home All News open_in_new Full Article

Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update

Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna’s 2025 advances across R&D, clinical development, and medical affairs. TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products applauds […]


today 2 h. ago attach_file Other

attach_file Economics
attach_file Other
attach_file Culture
attach_file Events
attach_file Events
attach_file Other
attach_file Other
attach_file Events
attach_file Politics
attach_file Transport
attach_file Other
attach_file Politics
attach_file Other
attach_file Other
attach_file Transport
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Other


ID: 1760253553
Add Watch Country

arrow_drop_down